Related Experiment Video
Updated: Mar 25, 2026
06:32
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
Published on: August 18, 2023
3.3K
Implication of immunokine profiling for cancer staging
Kawngwoo Park1, Madhusmita Dhupal2, Cheol-Su Kim2
1Department of Radiation Oncology, Wonju College of Medicine, Yonsei University, Wonju 26426, Republic of Korea.
Medical Hypotheses
|February 17, 2016
Summary
Immunokine profiling, analyzing cytokine and chemokine levels, can predict cancer stage and progression. This method offers a new tool for assessing patient prognosis and treatment outcomes in oncology.
Area of Science:
- Immunology
- Oncology
- Biochemistry
Background:
- Tumorigenesis is linked to immune system dysregulation.
- Immune cells release cytokines and chemokines during cancer development.
- Cytokine levels vary across tumor microenvironments and systemic circulation.
Purpose of the Study:
- To explore immunokine profiling as a predictive tool for cancer staging and progression.
- To evaluate the correlation between cytokine levels and patient prognosis.
- To build upon previous cytokine profiling feasibility studies.
Main Methods:
- Analysis of differential cytokine and chemokine levels.
- Comparison of local (intratumoral, peritumoral) and systemic (serum) sample sites.
- Correlation of immunokine profiles with cancer staging and progression.
Main Results:
- Demonstrated feasibility of cytokine profiling in a small patient cohort.
- Identified differential cytokine levels based on sample site.
- Established potential correlation between cytokine levels and prognosis.
Conclusions:
- Immunokine profiling shows promise as a surrogate marker for cancer staging.
- This approach may predict cancer progression and treatment outcomes.
- Further research is warranted to validate immunokine profiling in larger cohorts.
